阳光诺和：拟收购朗研生命并增持股份超30%

Core Viewpoint - The company plans to acquire 100% equity of Jiangsu Langyan Life Science Technology Holdings Co., Ltd. through the issuance of shares and convertible bonds, while also raising matching funds from no more than 35 specific investors [1] Group 1 - The controlling shareholder, Li Qian, and his concerted parties currently hold 28.27% of the company's shares, which will increase to over 30% post-transaction [1] - The company's board has proposed to the shareholders' meeting to approve Li Qian and his concerted parties' request to be exempt from making a tender offer for additional shares, pending approval from the shareholders' meeting [1]